Clinical Trials Browser

NIH × Endometrial Adenocarcinoma × GSK2141795 × Clear all

NCT01935973 2020-10-14

Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 1 Completed

Endometrial Adenocarcinoma